Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

By LabMedica International staff writers
Posted on 30 Sep 2026

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. More...

Current analytical methods can be complex, time-consuming, and dependent on specialized personnel, limiting their use for rapid onsite screening. To simplify this type of analysis, new findings demonstrate a laser-based approach that detects disease-associated odor signatures from simple swab samples.

The Fraunhofer Institute for Integrated Circuits IIS (Erlangen, Germany) and the Technical University of Dresden tested laser-based photoacoustic spectroscopy for detecting volatile organic compound patterns linked to disease. The measurement system developed at Fraunhofer IIS uses widely tunable quantum cascade lasers and a sensitive photoacoustic detector. The system generates characteristic spectral fingerprints of volatile organic compounds from swab samples taken from the anterior nasal cavity, navel, and outer ear, with nasal swabs described as particularly promising.

The proof-of-concept study was conducted under controlled laboratory conditions using participants randomly selected from the large-scale SMELLODI study. The cohort included 24 participants: six healthy controls, six people with Parkinson’s disease, six people with COVID-19, and six people with other conditions. Additional measurements taken two weeks later from three participants with Parkinson’s disease provided initial evidence that the results were stable over time. Statistical analysis also showed that the measurement scope could be significantly reduced without losing relevant information.

The study found differences between samples from healthy individuals and samples from people with Parkinson’s disease, COVID-19, and other diseases. The results were published in Scientific Reports under the title “Detection of disease-associated VOC signatures with laser-based photoacoustic spectroscopy (LPAS).”

Fraunhofer IIS developed the experimental setup, performed laboratory measurements, and conducted statistical analysis, while the Technical University of Dresden contributed medical and clinical expertise and coordinated recruitment, diagnosis, and sample collection. The approach is not yet a substitute for medical diagnosis, and larger studies involving more diverse participants under real-world conditions are needed before clinical use.

Related Links
Fraunhofer IIS
Technical University of Dresden


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Neurofilament Light Chain Assay
Lumipulse G NfL Blood
Gold Member
Platelet Function Analyzer
PL-12
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Measuring six variants from one sample may improve research efficiency and support clinical trials of amyloid biology in Alzheimer’s disease and related conditions (Image Credit: Adobe Stock)

Plasma Assay Measures Six Amyloid Beta Peptides for Alzheimer’s Treatment Research

Alzheimer’s disease research and related neurological studies often require tools that can characterize brain amyloid pathology and amyloid beta biology. Blood-based biomarker assays may help researchers... Read more

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.